Celularity Inc (CELU) stock
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.68−0.07 (-8.81%)
Close on Nov 12, 2026Market cap $22.22MP/E –Yield –
Celularity enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Celularity's enterprise value was $21.41M on Nov 11, 2026, against $91.98M a year earlier. Over the last 5 years it ranged from $15.18M to $1.40B, with a median of $78.01M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $21.41M | -68.0% |
| 2025 | Dec 31, 2025 | $66.87M | -14.3% |
| 2024 | Dec 31, 2024 | $78.01M | +66.6% |
| 2023 | Dec 29, 2023 | $46.82M | -72.2% |
| 2022 | Dec 30, 2022 | $168.21M | -69.1% |
| 2021 | Dec 31, 2021 | $544.70M | +974.8% |
| 2020 | Apr 30, 2020 | $50.68M | – |
See a number that looks wrong?